Prevalence of previously diagnosed diabetes and glycemic control strategies in Mexican adults: ENSANUT-2016

Abstract

Objectives To describe the prevalence of previously diagnosed diabetes among Mexican adults, to characterize the associated risk factors, and to describe which glycemic control strategies are the most used. Methods We analyzed data from 8,631 adults aged �20 years who participated in the ENSANUT-2016 and from whom we gathered data about previously diagnosed diabetes, risk factors, glycemic control strategies, and measures to prevent complications. Results The prevalence of previously diagnosed diabetes in Mexican adults was 9.4% (10.3% in women and 8.4% in men). The adjusted OR for having diabetes was higher in adults aged �60 years (OR = 11.0 in women and OR = 30.7 in men) than in adults aged 20-39 years (OR = 1.0). The adjusted OR for having diabetes was higher in overweight men (OR = 1.7) than in men with normal BMI (OR = 1.0). A total of 30.5% of adults with diabetes did not report any control strategies, 44.9% measured their venous blood glucose, and 15.2% used the HbA1C as an indicator of glycemic control. Only 46.4% of them reported preventive measures. Discussion Diabetes is a common disease among Mexican adults. Being older or overweight are risk factors for an adult to be diagnosed with diabetes. Most adults with diabetes evaluate their glycemic control but only half practice preventive measures.

Impact of a Double Epidemic in Mexico: Non-Communicable Diseases Increase the Case Fatality Rate with Covid-19

“…10 In China, reports indicate that among people ≥ 60 years, the risk of death was greater among those with two or more NCDs (RR = 2.59) in comparison to those with only one NCDs (RR = 1.79). [11][12][13][14][15][16] This is consistent with our ndings, where risk of death was also greater in adults ≥ 60 years and those with two or more NCDs (RR = 24.1) versus those with one (RR = 14.3).…”

“…15 It has been shown that NCDs increase the severity from COVID-19. In a country like Mexico where 49% of adults have hypertension, 16 14% have diabetes, 17 and 24% develop CVD, 18 it is important to quantify the risk of death among the population with NCDs and COVID-19. It is also important to consider the role of the health system providing care to patients with COVID-19 in cases with and without other NCDs.…”

Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico

“…Furthermore, our results suggest that obesity is a COVID- these factors remain to be confirmed by clinical evidence [30]. Given the large proportion of undiagnosed diabetes cases in Mexican and poor glycemic control reported by recent estimates, the burden of COVID-19 might be higher than expected in Mexico and poses a challenge for the Mexican healthcare system to give particular attention to this sector as the epidemic moves forward [31][32][33].…”

Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico

“…Additional factors which have been proposed to modify COVID-19 mortality risk and worsen glycemic control in diabetes include corticosteroid therapy, inadequate glucose monitoring, the effect of social distancing on diabetes care and the use of antihypertensive medication; however these factors remain to be confirmed by clinical evidence [30]. Given the large proportion of undiagnosed diabetes cases in Mexican and poor glycemic control reported by recent estimates, the burden of COVID-19 might be higher than expected in Mexico and poses a challenge for the Mexican healthcare system to give particular attention to this sector as the epidemic moves forward [31][32][33].…”